Rabeprazole sodium and Advair hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rabeprazole sodium (rabeprazole sodium) and Advair hfa (fluticasone propionate; salmeterol xinafoate). Common drug interactions include dyspnoea among females and sinusitis among males.

The phase IV clinical study analyzes what interactions people have when they take Rabeprazole sodium and Advair hfa. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Rabeprazole sodium?

Rabeprazole sodium has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 15,786 Rabeprazole sodium users. Check the latest studies of Rabeprazole sodium.

What is Advair hfa?

Advair hfa has active ingredients of fluticasone propionate; salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 69,790 Advair hfa users. Check the latest studies of Advair hfa.



On Jul, 09, 2026

72 people who take Rabeprazole sodium and Advair hfa together, and have interactions are studied.

Rabeprazole sodium and Advair hfa drug interactions.

What are the common drug interactions of Rabeprazole Sodium and Advair Hfa, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Heart rate increased
  3. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  4. Alopecia (absence of hair from areas of the body)
  5. Diarrhoea
  6. Oropharyngeal pain
  7. Rash
  8. Weight decreased
  9. Weight increased
  10. Wheezing (a high-pitched whistling sound made while you breath)

male:

  1. Sinusitis (inflammation of sinus)
  2. Weight decreased
  3. Anxiety
  4. Bacterial infection
  5. Benign prostatic hyperplasia (benign enlargement of the prostate)
  6. Bladder neoplasm (bladder tumour)
  7. Blood pressure fluctuation
  8. Cardiac failure congestive
  9. Chest discomfort
  10. Dehydration (dryness resulting from the removal of water)

What are the common drug interactions of Rabeprazole Sodium and Advair Hfa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Diarrhoea
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Weight increased

20-29:

n/a

30-39:

  1. Chest discomfort
  2. Cough
  3. Forced expiratory volume decreased (decreased lung expired air volume)
  4. Weight decreased
  5. Wheezing (a high-pitched whistling sound made while you breath)
  6. Allergy to chemicals
  7. Blood pressure increased
  8. Drug ineffective
  9. Dyspnoea (difficult or laboured respiration)
  10. Hypersensitivity

40-49:

  1. Blood cholesterol increased
  2. Cough
  3. Diarrhoea
  4. Drug ineffective
  5. Fungal infection
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Heart rate increased
  8. Hypersensitivity
  9. Hypertension (high blood pressure)
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)

50-59:

  1. Alopecia (absence of hair from areas of the body)
  2. Anxiety
  3. Asthenia (weakness)
  4. Burning sensation
  5. Chest pain
  6. Decreased appetite
  7. Depression
  8. Drug hypersensitivity
  9. Epistaxis (bleed from the nose)
  10. Erythema (redness of the skin)

60+:

  1. Pyrexia (fever)
  2. Urinary tract infection
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Neuropathy peripheral (surface nerve damage)
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  6. Pain in extremity
  7. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  8. Urine abnormality
  9. Mobility decreased (ability to move is reduced)
  10. Sinusitis (inflammation of sinus)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 13.89%
  2. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 9 people, 12.50%
  3. Dyspnea (difficult or laboured breathing): 6 people, 8.33%
  4. Pain: 5 people, 6.94%
  5. Nasopharyngitis (inflammation of the nasopharynx): 4 people, 5.56%
  6. Immunodeficiency Common Variable: 4 people, 5.56%
  7. Cough: 4 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole sodium and Advair hfa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rabeprazole sodium and Advair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rabeprazole sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Advair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rabeprazole sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Advair hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium and fluticasone propionate; salmeterol xinafoate (the active ingredients of Rabeprazole sodium and Advair hfa, respectively), and Rabeprazole sodium and Advair hfa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: